| NCT06628947 | A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa | RECRUITING | PHASE2 | 2025-08-29 | 2027-08 | 2027-08 |
| NCT06825702 | Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema | RECRUITING | PHASE2 | 2025-05-01 | 2026-12 | 2026-11 |
| NCT05629364 | A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune Disease | TERMINATED | PHASE2 | 2023-03-15 | 2024-01-09 | 2024-01-09 |
| NCT05282953 | A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS) | RECRUITING | PHASE1, PHASE2 | 2022-11-10 | 2026-07 | 2023-08-10 |
| NCT05436288 | A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects | COMPLETED | PHASE2 | 2022-07-01 | 2023-01-22 | 2022-12-22 |